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Background: Effective strategies for contacting and recruiting study participants are critical in conducting clinical
research. In this study, we conducted two sequential randomized controlled trials of mail- and telephone-based
strategies for contacting and recruiting participants, and evaluated participant-related variables’ association with
time to survey completion and survey completion rates. Subjects eligible for this study were survivors of acute
lung injury who had been previously enrolled in a 12-month observational follow-up study evaluating their
physical, cognitive and mental health outcomes, with their last study visit completed at a median of 34 months
previously.
Methods: Eligible subjects were contacted to complete a new research survey as part of two randomized trials,
initially using a randomized mail-based contact strategy, followed by a randomized telephone-based contact strategy
for non-responders to the mail strategy. Both strategies focused on using either a personalized versus a generic
approach. In addition, 18 potentially relevant subject-related variables (e.g., demographics, last known physical and
mental health status) were evaluated for association with time to survey completion.
Results: Of 308 eligible subjects, 67% completed the survey with a median (IQR) of 3 (2, 5) contact attempts
required. There was no significant difference in the time to survey completion for either randomized trial of
mail- or phone-based contact strategy. Among all subject-related variables, age ≤40 years and minority race were
independently associated with a longer time to survey completion.
Conclusion: We found that age ≤40 years and minority race were associated with a longer time to survey completion,
but personalized versus generic approaches to mail- and telephone-based contact strategies had no significant
effect. Repeating both mail and telephone contact attempts was important for increasing survey completion rate.
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Underpowered studies and insufficient sample sizes
often result, in part, from ineffective participant
contact methods and associated poor recruitment and
participation rates [1,2]. Unsuccessful participant con-
tact leads to extended recruitment time, missing data,
and increased cost and other resource utilization [3].
Nearly 60% of randomized controlled trials had diffi-
culties in meeting recruitment target or needed to
extend recruitment period [4]. Achieving a timely and
efficient strategy to contact research participants is
critical for conducting clinical research [4].
Several studies have shown that participants who
were female, Caucasian, younger, more educated, and
employed tend to have faster response to surveys [5-9].
However these findings are not universally confirmed,
with conflicting results regarding factors, such as
participant demographics and health status, influencing
participant recruitment and contact [10-18]. Some of
these conflicting results may be due to different patient
populations studied and different countries of research.
Hence, we aimed to evaluate predictors of survey com-
pletion in a patient population and U.S. study setting
similar to prior research by Chen et al. [13]. Chen et al.
[13] studied 146 acute lung injury (ALI) survivors from
a single-center, multi-site longitudinal observational
study based in the U.S.
Building on the results of Chen et al. [13], in the current
study, we evaluated a similar population of ALI survivors,
but with a larger sample size of 332 participants, recruited
from 41 hospital sites at 12 centers across the U.S. Like
Chen et al., this trial was conducted with participants
who had previously been enrolled in an observational
follow-up study evaluating physical and mental health
outcomes. In our current study, the last research evalu-
ation occurred a median of 34 months previously. As
part of this study, we asked participants to complete a
new one-page insurance survey that was not part of the
evaluation in their prior research visits.
The current study was conducted via two sequential
randomized controlled trials evaluating the effects of
different mail- and then telephone-based strategies for
contacting and recruiting participants, and evaluated
participant-related variables associated with time to
completing the survey. As commonly done in survey-
based research, the study protocol was designed with
initial participant contact via mail, with more resource-
intensive telephone contact reserved for non-responders
to the mailed survey [13,19-21]. Based on the results of
prior research [22-24] and the non-statistically significant
signal favoring personalized form of communications
observed in the smaller-sized study by Chen et al. [13],
we hypothesized that using personalized contact strat-
egies, such as hand-written envelopes for mail and usinga specific investigator’s name for telephone messages,
would result in a faster time to completing the survey
and a higher response rate. We also hypothesized that
for participants with poorer physical and mental health
status, at the time of last research contact, the time to
survey completion would be longer.
Methods
Study population
Participants in these two sequential randomized trials of
mail- and telephone-based contact strategies were part
of the ARDSNetwork Long Term Outcomes Study
(ALTOS) [25,26], which evaluated 6 and 12 months pa-
tient outcomes in acute lung injury survivors who were
enrolled in randomized trials of novel interventional
therapies funded by the National Heart, lung, and Blood
Institute (NHLBI) ARDS Network [27,28]. A new, brief,
one-page health insurance survey was introduced part-
way through ALTOS. A total of 332 ALTOS partici-
pants, who had been enrolled prior to introduction of
this survey, were sequentially randomized to mail- and
then telephone-based (for mail non-responders) strat-
egies, if needed, for contacting participants to complete
the survey. This study was approved by the Insti-
tutional Review Board at Johns Hopkins University.
Written or oral informed consent was obtained from all
participants in the study.
Standardized protocol for contacting participants
Within our two sequential randomized mail and tele-
phone trials of contact strategies, conducted from June
to December 2012, eligible subjects were contacted using
a multi-step, structured protocol starting with mailed
letters and then telephone calls, as needed for non-
responders to mailings. In the mail trial, participants
were mailed the insurance survey every 2 weeks until
the survey was completed or the participant was sent a
total of 4 mailings. For these mailings, trial participants
were randomized to receive either a “personal format
letter” in which their mailing address and the return
address were hand written and a traditional stamp was
stamped using the envelope versus a “business format
letter” in which the addresses were typed and the postage
was affixed by a commercial stamp-machine. In all other
respects, the envelopes were identical (i.e. 9 × 12 inch
manila envelopes) and included an identical cover letter,
insurance survey, and self-addressed return envelope.
Starting 20 days after the end of the mail trial, a
telephone trial was initiated. Non-responders from the
prior mail trial and those excluded from mail trial due
to lack of a correct mailing address were eligible for the
telephone trial. The telephone trial focused on the type
of messages left for participants via either an answering
machine/voicemail or a person (other than the participant)
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randomized to receive either a generic message in
which the caller said that she was “calling on behalf of
the ARDS Network Long-Term Outcomes study”, or a
personalized “ALTOS principal investigator message”
where the caller said she was “calling on behalf of Dr.
Dale Needham.” These telephone calls were made once
weekly by the same caller, for up to 4 weeks, until the
participant was reached by telephone or the participant
called back and completed the survey. If the partici-
pant answered the telephone and completed the survey
with no message ever left, the participant was excluded
from analysis of the telephone trial since they were not
exposed to the telephone message intervention. In
both the mail and the phone trials, randomization was
performed by a statistician using computer-generated
random numbers with an allocation ratio of 1:1.
Measurement of outcome and predictor variables
The primary outcome for analysis was the time (in days)
for the participant to complete the insurance survey,
analyzed separately for the sequential mail and telephone
trials. Given the nature of this study design, outcome
assessment was not blinded, but participants were blinded.
In the mail trial, time zero was defined as the first mailing,
using a valid address, to the participant. For the telephone
trial, time zero was the date of the first telephone message
to the participant. Given a lack of significant differences
between the randomized groups in both the mail and
telephone trial (see Results section), the participants
were subsequently pooled into a single cohort to evalu-
ate the association between the time to survey comple-
tion and potential predictors, using time zero from the
mail trial for all participants (except for those without a
valid mailing address in which time zero was defined
as the start of the phone trial). A total of 18 potential
predictors of time to survey completion were evaluated
in this pooled analysis, grouped into two categories: (1)
participant baseline demographics and time (in months)
since last follow-up with the ALTOS study, and (2)
physical and mental health status at last follow-up.
Participants’ baseline demographic factors evaluated were:
age, sex, race, and employment status. Participants’
physical and mental health status factors evaluated were:
physical functioning (using the Functional Performance
Inventory-Short Form (FPI) [29,30] total score and the
subscale scores for body care, physical exercise, and
maintaining household [for each, range 0–3; higher
score is better]), quality of life (using the Short Form-36
version 2 (SF-36) [31] physical and mental component
scores [range 0–100; higher score is better], as well as
EuroQol five dimensions questionnaire (EQ-5D) [32,33]
visual analogue scale score (VAS) [range 0–100; higher
score is better] and utility score [range −0.11-1.0; higherscore is better]), cognition (using Mini-Mental State
Examination (MMSE) telephone version converted score
[34] [range 0–30; higher score is better]), mental health
(using the Hospital Anxiety and Depression Scale (HADS)
[35] subscale scores for anxiety and for depression [for
each, range 0–21; lower score is better], as well as Impact
of Event Scale-Revised score (IES-R) [36,37] for post-
traumatic stress disorder symptoms [range 0–4; lower
score is better]), and fatigue (using the Functional Assess-
ment of Chronic Illness Therapy (FACIT) [38,39] fatigue
interval scale score [range 0–100; higher score is better]).
Statistical analysis
We compared participant demographics and physical
and mental health status among participant groups in
each of the sequential mail and the telephone ran-
domized trials using Fisher’s exact test (categorical
variables) and t-tests (continuous variables). P-values
for difference in survey completion rates between the
two randomized groups in each of the mail and the tele-
phone trials were calculated using two-sample test of
proportions. The distribution of time to survey comple-
tion was compared using Kaplan-Meier survival esti-
mates and log-rank tests. The associations between
participant demographics, time since last contact with
participant, and physical and mental health status with
time to survey completion were evaluated using bivari-
able hazard ratios (HRs) from simple Cox proportional
hazards regression models, and then evaluated via
adjusted hazard ratios in multivariable Cox models.
Since we had 183 responders and 18 predictors, the
ratio of the total number of responding participants to
the number of potential predictors was greater than 10
[40,41], so all variables were included in our multivari-
able model without substantial concern for overfitting.
Moreover, to further demonstrate no overfitting of the
model, we sequentially removed each of the two major
categories of predictor variables from the model and
confirmed no material change in the remaining vari-
ables’ associations with time to survey completion.
We confirmed that there was no violation of the
proportional hazards assumption by examining Schoenfeld
residual plots for each exposure and confirmed that there
was no multi-collinearity by evaluating variance inflation
factors [42,43]. Outliers and influential points were
assessed using Dfbeta statistics [44]. We verified the linear-
ity assumption for each continuous predictor variable, by
assessing plots of the variable versus Martingale residuals
from the Cox model. Only participant age demonstrated a
non-linear relationship with time to survey completion,
resulting in dichotomizing age as ≤40 versus >40 years old.
All p-values were two-sided, and statistical significance was
defined as p <0.05. All statistical analyses were performed
using Stata 13.0 (StataCorp, College Station, TX).
Table 1 Baseline characteristics of study population by treatment groups in mail and telephone randomized trials









Study name in message
(N = 86)
P.I. name in message
(N = 85)
Participant demographics and last contact
Age, mean (SD) 48.8 (15.0) 48.2 (15.4) 49.4 (14.7) 46.0 (14.7) 46.7 (14.0) 45.3 (15.5)
Male, n (%) 160 (48) 77 (46) 83 (50) 84 (49) 44 (51) 40 (47)
Minority2, n (%) 64 (20) 27 (17) 37 (23) 42 (26) 19 (23) 23 (28)
Employment status3
Employed (full- or part-time), n (%) 97 (30) 41 (25) 56 (34) 52 (31) 32 (38) 20 (24)
Unemployed, n (%) 79 (24) 43 (26) 36 (22) 43 (26) 15 (18) 28 (34)
Retired or disabled, n (%) 151 (46) 80 (49) 71 (44) 72 (43) 37 (44) 35 (42)
Months since last contact, mean (SD) 33.7 (7.3) 34.2 (7.2) 33.3 (7.4) 33.5 (7.5) 35.2 (7.1) 31.7 (7.5)
Physical and mental health status3, mean (SD)
FPI overall score 2.0 (0.7) 2.0 (0.7) 2.0 (0.7) 1.9 (0.7) 1.9 (0.8) 2.0 (0.7)
FPI body care subscale score 2.5 (0.6) 2.5 (0.6) 2.5 (0.6) 2.5 (0.7) 2.4 (0.7) 2.6 (0.6)
FPI maintaining household subscale score 1.9 (0.9) 1.9 (0.9) 1.9 (0.9) 1.9 (0.9) 1.8 (1.0) 1.9 (0.8)
FPI physical exercise subscale score 1.6 (0.9) 1.6 (0.9) 1.7 (0.9) 1.6 (0.9) 1.6 (1.0) 1.6 (0.9)
SF-36 Physical Component Summary 40.5 (12.5) 40.7 (12.4) 40.3 (12.7) 40.5 (12.8) 40.0 (13.3) 41.1 (12.3)
SF-36 Mental Component Summary 44.9 (14.8) 45.0 (14.4) 44.6 (15.2) 42.1 (14.8) 41.4 (14.3) 42.9 (15.3)
EQ-5D visual analogue scale 69.1 (22.7) 70.3 (22.3) 67.9 (23.0) 67.4 (23.7) 65.5 (24.2) 69.2 (23.3)
EQ-5D utility score 0.7 (0.2) 0.7 (0.2) 0.7 (0.2) 0.7 (0.3) 0.7 (0.3) 0.7 (0.2)
MMSE score 25.6 (1.9) 25.5 (2.0) 25.7 (1.8) 25.5 (2.2) 25.4 (2.6) 25.6 (1.7)
HADS-depression subscale score 6.0 (4.9) 5.9 (4.9) 6.2 (5.0) 6.7 (4.9) 6.8 (5.1) 6.6 (4.7)
HADS-anxiety subscale score 7.0 (5.1) 7.0 (5.3) 7.1 (4.9) 8.0 (5.0) 7.9 (4.7) 8.0 (5.2)
IES-R score 1.0 (1.0) 1.0 (1.0) 1.0 (1.0) 1.1 (1.0) 1.1 (1.0) 1.2 (1.0)
FACIT score 62.3 (18.6) 62.3 (20.0) 62.2 (17.1) 60.2 (16.9) 59.4 (15.6) 61.1 (18.0)
Abbreviations: SD (Standard Deviation), FPI (Functional Performance Inventory), SF-36 (Short Form-36 Health Survey), EQ-5D (EuroQol Five Dimensions Questionnaire), MMSE (Mini-Mental State Examination), HADS (Hospital
Anxiety and Depression Scale), IES-R (Impact of Event Scale-Revised), FACIT (Functional Assessment of Chronic Illness Therapy).
1Missing values for each variable: months since last contact (1, 1), white (12, 7), employment (5, 4), all FPI scores (10, 7), SF-36 Physical and Mental Component Summaries (17, 10), EQ-5D VAS (10, 7), EQ-5D utility (9, 6),
MMSE (20, 12), HADS subscales (14, 9), IES-R (16, 11), FACIT (16, 10).
2Minority race includes African American, Asian, American Indian and Alaskan Native.
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Overall recruitment
Participants in the study had a mean age of 49 years old,
52% women, 80% white, with 70% retired, disabled or
unemployed at their last study contact, with similar
characteristics between randomized groups (Table 1).
Randomized interventions
There are 332 subjects potentially eligible for the mail
trial (Figure 1) who were sent either personal (n = 166,
50%) or business (n = 166, 50%) format letters. After
excluding a total of 32 subjects not eligible to respond
and therefore not receiving the allocated intervention
(Figure 1), a total of 148 (49%) of 300 eligible subjects
completed the survey with the mail trial, of which 81
(52%) were in personal format group and 67 (47%) were
in business format group (p = 0.35). For the telephone
portion of the trial (Figure 2), 171 eligible subjects who
did not respond to the mail trial or had no valid mailing
address were contacted by telephone, of which 86 (50%)
were in the generic “ALTOS study” telephone message
group and 85 (50%) in personalized “ALTOS principalFigure 1 CONSORT flow diagram for mail trial. Mail survey completioninvestigator” message group. Among 84 participants
exposed to randomized phone message and eligible to
respond in the telephone trial, 35 (42%) completed the
survey, of which 19 (45%) were in the ALTOS study
telephone message group and 16 (38%) were in ALTOS
principal investigator message group (p = 0.51).
Figure 3 shows the Kaplan-Meier curves for time to sur-
vey completion for the entire cohort (Panel A), and for the
mail trial (Panel B) and the telephone trial (Panel C).
There was no significant difference in median (inter-quar-
tile range, IQR) time to survey completion between per-
sonal versus business format letter at 18 (7–38) versus 18
(5–36) days, with a bivariable hazard ratio (HR) (95% con-
fidence interval [CI]) of 1.16 (0.83-1.62, p = 0.383). There
was also no significant difference in median (IQR) time
to survey completion between generic “ALTOS study”
versus personalized “ALTOS principal investigator”
message group at 7 (1–15) versus 7 (1–15) days, with
a bivariable HR (95% CI) of 1.29 (0.66-2.51, p = 0.455).
In multivariable analyses these associations remain
non-significant for both the mail (HR, 95% CI: 1.05,
0.73-1.50, p = 0.797) and telephone (HR, 95% CI: 1.23,rate: (81 + 67) respondents/(157 + 147) potential respondents = 49%.
Figure 2 CONSORT flow diagram for phone trial. Telephone survey completion rate: [(19 + 16) respondents + (11 + 12) answered telephone
on first call]/(55 + 58) potential respondents = 51%. 1 Excluded from analysis of randomized trial of telephone messages, but censored in analysis
of the entire cohort. 2 Included in calculation of survey completion rate, but excluded from Cox models.
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pleted surveys, the median (IQR) number of contact
attempts was 2 (1, 3) in mail trial and 1 (1, 3) in tele-
phone trial.
Pooling of participants from randomized groups
Overall, when pooling participants from the two trials
(n = 332), after excluding 16 (5%) participants who died
and 8 (3%) who had no mailing address and active tele-
phone number for contacting the participant, there were
308 subjects eligible to respond, of whom 206 (67%)
responded and 10 (3%) declined to complete the survey.
Responders required a median (IQR) number of 3 (2, 5)
contact attempts (including both mail and/or telephone)
before survey completion.
Predictors of time to survey completion in pooled
participant cohort
Within the analysis of the pooled group of participants,
in simple Cox regression models (Table 2), 5 predictors
were significantly associated with time to survey com-
pletion: younger age, minority race other than white
(including African American, Asian, American Indianand Alaskan Native), and three measures of mental
health (SF-36 MCS, HADS-Anxiety subscale, and IES-R
PTSD symptom score). In multivariable Cox regression
analysis, only 2 variables were independently associated
with a significantly longer time to survey completion: (1)
age ≤40 years old (HR, 95% CI: 0.62, 0.41-0.95) and (2)
minority race (HR, 95% CI: 0.58, 0.36-0.93).
Discussion
We conducted two sequential randomized controlled
trials to evaluate separately the effects of personalized
versus generic mail- and telephone-based contact strat-
egies and also evaluated other potential predictors of
time to participant survey completion for 332 ALI survi-
vors recruited from 41 hospitals across the U.S. There
was no significant difference in time to survey comple-
tion or response rate between a “personal” versus gen-
eric “business” style of envelope in the mail trial, or for a
generic telephone message (that used the study name)
versus a personalized telephone message (that used the
principal investigator’s name) for non-responders to the
mail trial. Among 18 demographic and physical and
mental health status variables evaluated, only younger
Figure 3 Estimated proportions of participants remaining to be
contacted over time. These 3 panels display the survival function
for time to survey completion since randomization for the mail- and
telephone-based randomized trials. Panel A displays the overall survival
function for all participants participating in the trials. Panels B and C
display the survival function for the mail and telephone randomized
trials, respectively.
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independently associated with a significantly longer time
to survey completion within this sequential protocol of
repeated mail then telephone contact strategies.
A multi-modal contact strategy, such as mail followed
by telephone calls, and making repeated contact attempts,
as done in this study, is typical of rigorous approaches
for minimizing participant loss to follow-up and associ-
ated missing data [19-21]. In our study, this approach
involved active contact for up to 12 weeks (maximum of
4 bi-weekly mailings and 4 weekly telephone calls) with
participants who were last contacted approximately
3 years earlier. Via this approach, we achieved an overall
survey completion rate of 67%, with only 3% declining
participation, and required a median (IQR) of 3 (2, 5)
contact attempts among respondents. This combined
67% survey completion rate, with individual response
rates of 49% in the mail trial and 51% in the telephone
trial, compares favorably with other studies [10,22,45].
Comparison of response rates between the mail versus
telephone trials within our study was not conducted
since participants in telephone trial represented non-
responders from mail trial or participants without a
valid mailing address, and thus a different population
from the mailing trial. Contrary to our hypotheses
developed based on prior studies [13,22-24], we did not
observe a significantly shorter time to survey comple-
tion or a higher response rate with more personalized
contact formats, such as a personal envelope format
and a telephone message using a the principal investiga-
tor’s name (“Dr. Dale Needham”).
Relatively few studies have evaluated factors predicting
time to participant survey completion [10,46]. Tennant
and Badley [46] evaluated age as a single predictor
for non-response bias, while Chen et al. [13] did not
explicitly evaluate the effects of participants’ objective
physical and mental health status. Although Chen’s
study [13] found no association of any participant
demographics with time to survey completion, we found
significant associations for age and race. Our study
demonstrated that participants ≤40 years old had a
longer time to survey completion. This finding is similar
to the results of Tennant and Badley [46] who demon-
strated that participants ≤65 years old who were physically
independent had a tendency to slower survey completion.
We speculate that younger patients, especially after acute
lung injury, may be less physically impaired and spent less
time at home, making them less readily available to
respond [25,26,47,48]. Alternatively, expanded use of
mobile phones among younger adults may make them
more responsive to telephone versus mail communication;
thus, the slower time to survey completion for younger
patients may be a result of initial contact attempts being
made via mail. Another potential explanation is that
Table 2 Bivariable and multivariable associations of baseline characteristics with time to survey completion in entire
cohort
Bivariable model Multivariable model
Predictors HR (95% CI)1 P-value HR (95% CI)1 P-value
Participants demographics and last contact
Age ≤40 years old 0.64 (0.45, 0.92) 0.016 0.62 (0.41, 0.95) 0.029
Male 0.86 (0.64, 1.16) 0.315 0.70 (0.49, 1.01) 0.052
Minority2 0.55 (0.35, 0.84) 0.006 0.58 (0.36, 0.93) 0.023
Employment status3
Employed (full- or part- time) Ref Ref
Unemployed 0.95 (0.62, 1.44) 0.789 1.11 (0.71, 1.74) 0.653
Retired or disabled 1.27 (0.89, 1.79) 0.184 1.31 (0.83, 2.09) 0.248
Month since last contact 1.00 (0.98, 1.02) 0.869 0.99 (0.97, 1.01) 0.465
Physical and mental health status3
FPI overall score 1.10 (0.88, 1.37) 0.418 0.84 (0.45, 1.56) 0.584
FPI body care subscale score 1.26 (0.96, 1.65) 0.099 1.27 (0.77, 2.10) 0.350
FPI maintaining household subscale score 1.06 (0.89, 1.26) 0.532 1.08 (0.71, 1.65) 0.709
FPI physical exercise subscale score 1.07 (0.90, 1.26) 0.443 1.13 (0.79, 1.62) 0.497
SF-36 Physical Component Summary 1.00 (0.99, 1.01) 0.805 0.99 (0.96, 1.02) 0.487
SF-36 Mental Component Summary 1.01 (1.00, 1.03) 0.010 1.01 (0.99, 1.04) 0.262
EQ-5D visual analogue scale 1.00 (0.99, 1.01) 0.201 1.00 (0.99, 1.01) 0.607
EQ-5D utility score 1.41 (0.75, 2.66) 0.290 0.97 (0.25, 3.70) 0.960
MMSE score 1.01 (0.92, 1.11) 0.835 0.95 (0.85, 1.07) 0.420
HADS-depression subscale score 0.97 (0.94, 1.00) 0.067 1.02 (0.95, 1.09) 0.445
HADS-anxiety subscale score 0.96 (0.93, 0.99) 0.008 0.99 (0.93, 1.06) 0.810
IES-R score 0.84 (0.71, 0.99) 0.040 1.07 (0.79, 1.45) 0.652
FACIT score 1.01 (0.99, 1.02) 0.068 1.01 (0.99, 1.03s) 0.223
Abbreviations: SD (Standard Deviation), HR (Hazard Ratio), CI (Confidence Interval), FPI (Functional Performance Inventory), SF-36 (Short Form-36 Health Survey),
EQ-5D (EuroQol Five Dimensions Questionnaire), MMSE (Mini-Mental State Examination), HADS (Hospital Anxiety and Depression Scale), IES-R (Impact of Event
Scale-Revised), FACIT (Functional Assessment of Chronic Illness Therapy).
1A hazard ratio (HR) < 1 indicates a longer time to contact with the participant. All the significant associations (p<0.05) in models are highlighted in bold.
2Minority race includes African American, Asian, American Indian and Alaskan Native.
3Status as at last contact with research participant.
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frequently than older participants. In addition, our study
demonstrated that although several predictors of physical
and mental health status had a significant association with
time to survey completion in bivariable Cox models, they
were not significant in multivariable analyses. Since the
last study contact, for purposes of evaluating health status,
was approximately 3 years earlier, this timing issue may
have contributed to a lack of effect; however, specifically
in ALI survivors, physical and mental health impairments
are long-lasting [47,49-51] which justified their evaluation
in this study.
The median (IQR) number of contact attempts was 2
(1, 3) in the mail trial among those participants who
completed the survey, which demonstrates that repeated
attempts within a single contact modality are needed forsurvey completion. However, we observed a decreasing
rate of survey completion over time in the mail and
telephone trials (Figure 3), indicating that with repeated
failed contact attempts, non-responders were less likely
to respond. However, after changing from mail to tele-
phone contact, additional participants were successfully
contacted, with 51% of eligible participants completing
the survey with a median (IQR) of 1 (1, 3) telephone
calls among respondents. This finding suggests that the
effects of single contact method (e.g. mail), despite some
improvement with repetition, may be not adequate for
timely and maximal participation. Utilizing at least two
different types of contact strategies can increase partici-
pant response rate in clinical studies.
There are several potential limitations in our study.
First, our study focuses on survivors of ALI, so our
Dinglas et al. BMC Medical Research Methodology 2015, 15:5 Page 9 of 11
http://www.biomedcentral.com/1471-2288/15/5findings may or may not be generalizable to other
specific populations. However, this research was a national
study of participants initially recruited from 41 hospitals
in United States, so our findings may be generalizable to
similar populations across the U.S. Second, there was a lag
between the participant’s last visit at the end of the
ALTOS study and our attempt to contact them in this
trial, so their employment and physical and mental health
status may have changed over time, impairing our ability
to identify the true association between these variables
and survey completion. Third, our analyses may have
omitted potentially relevant predictor variables that were
not available for analysis in this study. For instance, Chen
et al. [13] evaluated factors related to prior research visits
(e.g., incomplete data collection and missed visits), and
revealed significant associations with participant contact.
Moreover, other comorbidities and disease history, not
evaluated in this study, may be related to timing of survey
completion. Fourth, the difference between our contact
strategies (generic versus personal) may have been too
small to yield a significant difference in participant percep-
tions and response times. However, we felt that our inter-
ventions were not markedly different from prior studies
[22-24] that demonstrated a substantial difference in
response rates between personal and generic contact
strategies. Additionally, it’s possible that the personal-
ized contact strategy would, in fact, shorten response
time had these participants not already been enrolled in a
lengthy study. However, their prior involvement may
not have played a large role since this trial was con-
ducted 3 years after their last follow-up visit. Lastly, the
questionnaire mailed was a single-page, retrospective
survey of insurance coverage status. Perhaps faster
response time and higher responses rates would have been
achieved, in the mailing portion of the trial, if the survey
was more intriguing to the participant.
Conclusion
Repeated attempts using both mail- and telephone-based
contact strategies are important for effectively reaching a
majority of ALI survivors for completion of a simple,
one-page health insurance survey. More personalized
contact strategies (e.g. personalized format letter, and
use of an investigator’s name in telephone messages)
were not associated with a significantly faster time to
survey completion. Although participants’ prior employ-
ment and physical and mental health status were not
independently associated with a shorter time to survey
completion, participants who were minority and aged
under 40 years old had a significantly longer time to
survey completion. Greater contact efforts and novel
investigation of contact methods are needed for maxi-
mizing survey completion rates, especially for younger
participants and racial minorities.Competing interests
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